Company / Book Value per Share
Summit Therapeutics Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.881
FY2025
5-year range
$0.248 / $0.881
FY2021-FY2025
Trend
+59.0%
vs FY2024
Sector context
#171 of 209
Health Care
What the data says
Summit Therapeutics Inc.'s book value per share of $0.881 is lower than 82% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 7 years, ranging from $0.248 in FY2021 to $2.402 in FY2019.
Based on SEC 10-K filings.
$0.881 in FY2025 with a 5-year CAGR of -5.7%.
Improved from $0.368 to $0.881 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- -5.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 209This company $0.881 Sector average $189.406
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.7%, indicating a declining trend.
- In FY2025, book value per share increased 59.0% year-over-year.
- Ranks #171 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.881 | +59.0% |
| FY2024 | $0.554 | +50.5% |
| FY2023 | $0.368 | -56.7% |
| FY2022 | $0.849 | +242.9% |
| FY2021 | $0.248 | -79.1% |
| FY2020 | $1.183 | -50.8% |
| FY2019 | $2.402 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026